Clinical Trials Browser

Has results × Liver Neoplasms × Capecitabine × Clear all

NCT03111732 2021-12-03

Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

Phase 2 Completed

11 enrolled 16 charts

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Cholangiocarcinoma

NCT01032850 2021-06-02

Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma

Phase 2 Terminated

15 enrolled 8 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00483405 2017-07-12

NRR

Phase 2 Completed

33 enrolled 14 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03026803 2017-04-13

A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer

Phase 2 Terminated

4 enrolled 4 charts

Gastrointestinal

Liver Neoplasms

NCT01151761 2016-07-29

Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation

Phase 2 Terminated

2 enrolled 9 charts

Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Cholangiocarcinoma

NCT02013830 2014-06-06

A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer

Phase 2 Completed

45 enrolled 13 charts

Gastrointestinal

Liver Neoplasms